Kisunla Clears 79-Year-Old Florida Patient's Brain Plaques After 18 Months

1 articles · Updated · VINNews · Sep 6

18 months of Kisunla infusions left Scott Milinski, 79, with no detectable amyloid plaques on follow-up testing, Broward Health said.
PET scans, MRI, blood biomarker tests and cognitive assessments had confirmed Alzheimer’s-linked plaques before treatment and were used again to monitor his response.
Broward Health said Milinski was the second person in Florida to receive the FDA-approved drug, which is given every four weeks and slowed Alzheimer’s progression by up to 30% in trials.
More than 60 patients are now receiving Kisunla at Broward Health’s Memory Disorder & Alzheimer’s Center, which stressed the treatment is not a cure but aims to slow the disease.